芳呋喃吡唑啉的合成和波谱研究

合成了14种新的1-苯基-5-对二甲胺基苯基-3-芳呋喃基及3-芳呋喃乙烯基吡唑啉衍生物。测定了它们的紫外、红外、核磁、质谱和荧光光谱。对合成反应过程中缩合环化方向进行了讨论。初步考察了所得吡唑啉的光导电性和电致变色性质。     

三芳基吡唑啉噁二唑类衍生物的合成及其荧光光谱研究

提出了一种新的合成1,3,4-噁二唑化合物的方法,并通过Wittig反应将其与1,3,5-三芳基-2-吡唑啉相连合成了6种新的三芳基吡唑啉噁二唑类化合物.用红外光谱、质谱、核磁共振谱和元素分析对合成化合物进行了结构表征.用荧光光谱仪对它们的荧光性能进行了测试,测试结果表明目标产物具有良好的荧光性,其荧光发射波长均在437～511nm范围内,荧光量子产率最大可达0.36.     

异噁唑基取代的1,2,4-噁二唑啉和吡唑啉类化合物的合成

通过3-乙酰基-5-羟甲基异噁唑衍生的Schiff碱2与由醛肟原位生成的腈氧化物的1,3-偶极环加成反应, “一锅法”制备了5-甲基-5-[5-(叔丁基二甲基硅氧基甲基)-3-异噁唑基]-3-芳基-4-(4-甲氧基苯基)-4,5二氢-1,2,4-噁二唑类化合物4a～4e; 同时由3-乙酰基-5-羟甲基异噁唑衍生的α,β-不饱和酮(5)与取代苯肼的环化反应制备了5-(叔丁基二甲基硅氧基甲基)-3-[(1,5-二芳基)-3-(4,5-二氢吡唑基)]-异噁唑类化合物6a～6i. 所有新化合物的结构经核磁共振谱氢谱和碳谱、质谱、红外光谱以及高分辨质谱等进行了确证.     

3-乙酰基-2-芳基-5-(6-吲哚基)-1,3,4-噁二唑啉化合物的微波合成及表征

噁二唑啉化合物由于具有杀虫[1],杀菌[2],抗艾滋病毒[3]等生物活性受到药物化学家的广泛关注.而吲哚因独特的化学结构使其衍生出的化合物显示出重要的生物活性,如抗疟疾[4]、抗肿瘤[5]、抗糖尿病[6]等,可以用作HT受体抑制剂[7]、环氧酶抑制剂[8]等.鉴于不同活性的基团在同一分子中聚集能明显改善化合物的生物活性这一特性,本文将吲哚引入到噁二唑啉化合物中,以期实现活性的叠加,从而发现新的生物活性更好的化合物.     

双吲哚啉螺吡喃化合物的合成及其酸和金属离子致变色性能

设计、合成了一种新型双吲哚啉螺吡喃化合物1,用核磁、红外及质谱等技术手段表征了其结构。 利用紫外可见吸收光谱研究了化合物1的酸致变色和金属离子变色性能。 结果表明,化合物1能够在氢离子或金属离子的作用下发生可逆的开环与闭环反应。 当氢离子或金属离子加入到化合物1的异丙醇溶液中,溶液颜色从无色变为红色,同时产生460 nm新吸收峰。 进一步加入氢氧根离子或EDTA溶液后,溶液颜色变回无色,460 nm处的吸收峰又消失。 该化合物的酸和金属离子致变色性质在分子传感和离子识别等领域有潜在的应用价值。     

微波辐射下吲哚连噁二唑啉衍生物的合成和抗菌活性测定

把噁二唑结构引入吲哚环中,合成一类结构新颖的吲哚衍生物,以期为新药筛选提供先导化合物.在微波辐射条件下,以较高的产率得到9个未见文献报道的新化合物,其结构均经1HNMR,IR,MS及元素分析所证实,并测试了化合物的抑菌活性.     

含有异(口恶)唑的S-三唑[3,4-b]-1,3,4-噻二嗪、咪唑[2,1-b]-1,3,4-噻二唑和咪唑[2,1-b]-1,3,4-(口恶)二唑衍生物的合成

异噁唑衍生物作为一类重要的生物活性物质[1,2],其合成一直受到人们的关注,其中德国HMR公司开发研制的新型抗内风湿性关节炎药来氟米特(Leftunomide)已于1998年在美国率先上市,该药还具有很好的免疫调节作用[3].7H-均三唑[3,4-b]-1,3,4-噻二嗪、咪唑并[2,1-b]噻唑和咪唑并[2,1-b]-1,3,4-噻二唑衍生物均表现出广谱的生物活性[4～6].     

含吲哚的吡唑并[3,4-d]嘧啶衍生物的设计合成及其生物活性研究

利用药物设计中的生物活性基团拼接原理,设计合成了13个含吲哚的吡唑并[3,4-d]嘧啶衍生物.目标化合物均经核磁共振氢谱(1H NMR)、核磁共振碳谱(13C NMR)和高分辨质谱仪(HRMS)进行了结构确证.对4株肿瘤细胞(HeLa、MGC-803、MCF-7、BEL-7404)的体外抗增殖活性实验结果表明,目标化合物均表现出一定的抗肿瘤活性,MCF-7、MGC-803肿瘤细胞株敏感度高于HeLa和BEL-7404.其中, 6-[(6-甲氧羰基吲哚-3-基)硫基]-1-苯基-吡唑并[3,4-d]嘧啶-4-酮(5m)表现出较好的体外肿瘤抑制活性,对MCF-7、MGC-80和HeLa细胞的IC50均小于30μmol·L^-1,对MCF-7的IC50值为(4.02±0.92)μmol·L^-1,优于对照药物依托泊苷(10.1±0.62μmol·L^-1)和羟喜树碱(5.93±0.56μmol·L^-1).拓扑异构酶抑制实验结果表明,此类化合物对TopoII有选择性抑制活性,所有化合物对TopoⅡ表现出不同程度抑制活性,对Topo Ⅰ未表现出抑制活性.     

手性2-(口恶)唑烷酮的无溶剂合成法

在无溶剂条件下,手性的β-氨基醇和脲在160-180℃反应0．5-1 h,在200℃反应0．5 h,高产率地获得手性噁唑烷酮。     

Pyrimidinthiones (Part I): Utility of 2-Thioxopyrimidin-6-(1H)ones as Ring Transformer in the Synthesis of Fused Bi- and Tri-Cyclic Heterocyclic Compounds and Their Potential Biological Activities

The pyrimidinethiones have wide biological and pharmaceutical activities, that have attracted considerable interest in recent years especially as antiviral inhibiting production of hepatitis B virus (HBV), and in vitro insulin-mimetic. Activity of the complexes of pyrimidinone derivatives evaluated from 50% inhibitory concentration promoted us to study the transformation of the 2-thioxopyrimidin-6(1H) ones to fused bi- and tri-cyclic heterocyclic compounds having the pyrimidine moieties and screening their biological activity.

The reactivity of 2-mercapto-4-aryl-5-cyanopyrimidin-6(1H)ones (1) towards alkylation by different mono and bifunctional halo-organic compounds has been investigated to give S-monoalkylated products 2, 7 and 9; S- and N-dialkylated products 3, 13 and 14. Treatment of 1 and/or 2 with hydrazine hydrate as a nitrogen nucleophile have been investigated to give 4, treatment of 4 with CS₂ and sodium nitrite in the presence of acetic acid (0°C) produced 1,2,4-triazolopyrimidin-5(1H)one derivatives (5)and tetrazolo[1,5-a]pyrimidin-5(1H)ones (6), respectively. Also cyclization of 7 and 9 gave [1,3]thiazolo[3,2-a]pyrimidin-5(1H)one and [1,3]thiazolo[3,2-a]pyrimidin-3,5-dione derivatives 8 and 10 respectively, treatment of 10 with aromatic aldehyde produces 11 which reacted with guanidine HCl to give pyrimido[4,5-d]thiazolo[3,2-a]pyrimidin-6(1H)one derivative 12. Reaction of 14 with o-phenylenediamine was investigated and gave [1,4]quinoxalino[2,3-b][1,3]thiazolo[3,2-a]pyrimidin-9(1H)one derivative 15.     

Synthesis of some novel pyrazolo[1,5-a]quinazolines and their fused derivatives

New pyrazolo[1,5-a]quinazoline-3-carbonitriles 4a,b were obtained via cyclocondensation of 5-amino-3-cyanomethyl-1H-pyrazole-4-carbonitrile (1) with enaminones of 1,3-cyclohexanedione derivatives 2a,b in refluxing glacial acetic acid. Condensation of compounds 4a,b with various aromatic aldehydes furnished the corresponding arylidene derivatives 6a–j. On the other hand, condensation of 4a,b with o-hydroxybenzaldehydes yielded the polyheterocyclic compounds 10a–h. Coupling of compounds 4a,b with aryldiazonium chlorides led to formation of 2-arylhydrazono derivatives 12a–h. Also, reaction of compounds 4a,b with phenyl isothiocyanate, followed by addition of ethyl chloroacetate and chloroacetonitrile, afforded the polyheterocyclic compounds based on pyrazolo[1,5-a]quinazoline core. The reaction of compounds 4a,b with phenyl isothiocyanate and elemental sulfur gave the thiazole-2-thione derivatives 25a,b. The reaction of enamines of compounds 4a,b with each of hydrazine hydrate and guanidine hydrochloride afforded pyrazolo[4″,3″:5′,6′]pyrido[4′,3′:3,4]pyrazolo[1,5-a]quinazolin-8-ones 30a,b and pyrimido[5″,4″:5′,6′]pyrido[4′,3′:3,4]pyrazolo[1,5-a]quinazolin-9(10H)-ones 33a,b, respectively. The structures of all the newly synthesized compounds were elucidated by elemental analyses and spectral data. The plausible mechanisms have been postulated to account for their formation.     

Reactions of 2-Cyano-2-nitrosomethylbenzthiazole: One-Pot Synthesis of New Polyfunctional Pyrazine Derivatives

2-Cyano-2-nitrosomethylbenzthiazole reacts with some active methylene and nucleophile derivatives to yield new fused and isolated polyfunctional pyrazine, -[1,2,4]triazine, -[1,4,5]benzoxadiazepin, -[1,4,5]benzothiadiazepine, [1,4,5]benzotriazepine, -triazole and -triazolo[3,2-c]triazine derivatives in one-pot reaction. The structures were based on IR, MS, and 1 H NMR spectra and elemental data.     

Azolo[1,5-a]pyrimidines and Their Condensed Analogs with Anticoagulant Activity

Hypercytokinemia, or cytokine storm, is one of the severe complications of viral and bacterial infections, involving the release of abnormal amounts of cytokines, resulting in a massive inflammatory response. Cytokine storm is associated with COVID-19 and sepsis high mortality rate by developing epithelial dysfunction and coagulopathy, leading to thromboembolism and multiple organ dysfunction syndrome. Anticoagulant therapy is an important tactic to prevent thrombosis in sepsis and COVID-19, but recent data show the incompatibility of modern direct oral anticoagulants and antiviral agents. It seems relevant to develop dual-action drugs with antiviral and anticoagulant properties. At the same time, it was shown that azolo[1,5-a]pyrimidines are heterocycles with a broad spectrum of antiviral activity. We have synthesized a new family of azolo[1,5-a]pyrimidines and their condensed polycyclic analogs by cyclocondensation reactions and direct CH-functionalization and studied their anticoagulant properties. Five compounds among 1,2,4-triazolo[1,5-a]pyrimidin-7-ones and 5-alkyl-1,3,4-thiadiazolo[3,2-a]purin-8-ones demonstrated higher anticoagulant activity than the reference drug, dabigatran etexilate. Antithrombin activity of most active compounds was confirmed using lipopolysaccharide (LPS)-treated blood to mimic the conditions of cytokine release syndrome. The studied compounds affected only the thrombin time value, reliably increasing it 6.5–15.2 times as compared to LPS-treated blood.     

Recent Advances in the Synthesis of Isoquinoline-Fused Benzimidazoles

This review includes recent developments in the synthesis of benzo[4,5]imidazo[2,1-a]isoquinolines with particular attention given to categorizing protocols based on the structural features of the ring architecture and crystallographically characterized reaction products.     

Studies on the Synthesis of New 3-(3,5-Diamino-1-substituted-pyrazol-4-yl)azo-thieno[2,3-b]pyridines and 3-(2-Amino-5,7-disubstituted-pyrazolo[1,5-a]pyrimidine-3-yl)azothieno[2,3-b]pyridines

Coupling the diazonium salt of 3-amino-2-cyano-4,6-dimethylthieno[2,3-b]pyridine 1 with malononitrile 2 gave 2-cyano-3-(hydrazonomalononitrile)-4,6-dimethylthieno[2,3-b]pyridine 3 which then reacted with hydrazine compounds 4a-4h to yield corresponding 2-cyano-3-(3,5-diamino-1-substituted-pyrazol-4-yl)azo-4,6-dimethylthieno[2,3-b]pyridines 5a-5h. The 2-cyano-3-(2-amino-5,7-disubstituted-pyrazolo-[1,5-a]pyrimidine-3-yl)azo-4,6-dimethylthieno[2,3-b]pyridines 7a-7f were obtained in good yield by the cyclocondensation reaction of 2-cyano-3-(3,5-diamino-pyrazol-4-yl)azo-4,6-dimethylthieno[2,3-b]pyridine 5a with the appropriate 1,3-diketones 6a-6f under acidic condition.     

功能化碳纳米管的电化学性质及在6-巯基嘌呤分析检测中的应用

采用修饰单壁碳纳米管(SWNT、SWNT-COOH或SWNT-OH)及多壁碳纳米管(MWNT、MWNT-COOH或MWNT-OH)的石墨电极研究配位阴离子[Fe(CN)6]3-和配位阳离子[Co(phen)3]3+的电化学行为与吸附性能,借助[Co(phen)3]3+在碳纳米管(CNT)的强吸附特性制备[Co(phen)3]3+/CNT/C修饰电极,以其应用于6-MP的分析检测.结果表明:1)在CNT修饰电极上[Fe(CN)6]3-/4-呈现很好的氧化还原可逆性,而[Co(phen)3]3+则显示明显的吸附控制特征.2)[Co(phen)3]3+在多壁碳纳米管修饰电极上的吸附量较单壁碳纳米管大,但经羧基化或羟基化后,吸附量减小,而且在羧基化表面的吸附量较羟基化的大.3)[Co(phen)3]3+与6-MP间存在明显的相互作用,其配位产物的还原峰电流与6-MP浓度呈线性关系.     

Synthesis, Crystal Structure, Fluorescence Properties and Geometrical Calculation of 4,8,10-Trimethyl-2-(3,5-dimethylpyrazol)pyrido-[2',3':3,4]-pyrazol[1,5-a]-pyrimidin

A novel compound 4,8,10-trimethyl-2-(3,5-dimethylpyrazol)-pyrido-[2',3':3,4]-pyrazol-[1,5-5-a]-pyrimidine (C17H18N6) has been synthesized from 2,6-dichloro-4-methylnico-tinonitrile, hydrazine and acetylacetone by substitution and cyelolization. The structure was characterized by elemental analysis, 1H NMR and IR, and single-crystal structure was determined by X-ray diffraction analysis. The compound crystallizes in the monoclinic system, space group P21/c with a = 8.0338(9), b = 28.618(3), c = 7.2688(8) (A),β = 111.051(2)°, V= 1559.6(3) (A)3, Z = 4, Dc=1.305 g/cm3,μ = 0.083 mm-1, Mr = 306.37, F(000) = 648, S = 0.971, the final R = 0.0795 and wR =0.1746 for 1457 observed reflections (Ⅰ > 2σ(Ⅰ)). The results demonstrate that the pyridine, pyrazole and pyrimidine rings are nearly eoplanar, which is evident from the dihedral angles among the four rings in the range of 0.13～4.15°. The face-to-face π-π stacking interactions among pyridine,pyrazol and pyrimidine rings result in a supramolecular crystal, in which they seem to be effective in stabilizing the structure. Meanwhile, the fluorescence properties of the title compound were discussed, which showed very strong fluorescence. The calculated results (selected bond lengths,bond angles and torsion angles) are all typical and agree well with the experimental results, which demonstrates that B3LYP/6-31+G* is suitable for the title compound.     

Regioselective Synthesis of Indolizines,Pyrrolo[2,1-a]isoquinolines,and Quinolines

Convenient and regioselective synthesis of indolizine and pyrrolo[2,1-a]isoquinoline/quinoline derivatives by one-pot multicomponent reaction of N-substituted pyridinium and isoquinolinum/quinolinium salts with alkyl propiolates in the presence triphenylphosphine is described.     

Synthesis of heterocyclic methylenebisphosphonates by 1,3-dipolar cycloaddition of ethyl diazoacetate to 1,2-benzoxaphosphorin-3-phosphonates

Reaction of salicylaldehydes with tetraethyl ester of methylenebisphosphonic acid, under Knoevenagel reaction conditions, gives the corresponding 1,2-benzoxaphosphorin-3-phosphonates 5 in good yields. The [3+2] regio- and stereoselective cycloaddition of 5a and 5b with ethyl diazoacetate gives two P-4 epimers of the corresponding pyrazoline bisphosphonate tetraethyl esters 9 and 10. Analogously, ethyl diazoacetate reacts with 1 and 2 to give the expected pyrazolines 6-8. The structures of the new compounds are revealed and confirmed by analytical, spectroscopic data and X-ray crystallographic analysis.